Neuca (LTS:0MJR) EBIT: zł282 Mil (TTM As of Mar. 2026)

What is Neuca EBIT?

Neuca LTS:0MJR 98 EBIT is zł282 Mil as of Mar. 2026. GuruFocus rates LTS:0MJR with a GF Score™ of 98/100 and a GF Value™ of zł938.86. The stock has 4 warning signs investors should review.

Neuca's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was zł104 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was zł282 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neuca's annualized ROC % for the quarter that ended in Mar. 2026 was 11.12%. Neuca's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 55.92%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Neuca's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.35%.

Neuca (LTS:0MJR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neuca's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	403.42 * ( 1 - 22.86% )	/	( (2761.707	+	2835.314)	/ 2 )
=	311.198188	/	2798.5105
=	11.12 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6242.08	-	3993.358	-	( 168.618	-	max(0, 4686.46	-	4173.475	+	168.618	))
=	2761.707

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6135.546	-	3755.463	-	( 185.272	-	max(0, 4493.384	-	4038.153	+	185.272	))
=	2835.314

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Neuca's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	416.52	/	( ( (747.586 + max(-385.534, 0))	+	(742.028 + max(-225.742, 0)) )	/	2 )
=	416.52	/	( ( 747.586	+	742.028 )	/	2 )
=	416.52	/	744.807
=	55.92 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2002.638	+	1926.293	+	23.557)	-	(3993.358	+	0	+	344.664)
=	-385.534

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2034.836	+	1786.011	+	10.888)	-	(3755.463	+	0	+	302.014)
=	-225.742

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Neuca's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	282.163	/	3840.822
	=	7.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca EBIT Related Terms

Neuca EBIT Historical Data

* Premium members only.

The historical data trend for Neuca's EBIT can be seen below:

Neuca EBIT Chart

Neuca Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

213.70

251.98

285.14

297.70

265.25

Neuca Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															87.22	52.76	84.63	40.64	104.13

LTS:0MJR vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Neuca's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuca EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neuca's EV-to-EBIT falls into.

Save Embed

98GF Score

Neuca SA LTS:0MJR

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Neuca EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł282 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of zł282 Mil mean?

Neuca (LTS:0MJR) has a EBIT of zł282 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Neuca.

Is Neuca's EBIT too high?

Neuca's current EBIT is zł282 Mil. Overall, Neuca has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.

How does Neuca's EBIT compare to MCK and COR?

Neuca's EBIT of zł282 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Medical Distribution company?

A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Neuca. Neuca's current EBIT is zł282 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Neuca stock overvalued right now?

Neuca (LTS:0MJR) has a current EBIT of zł282 Mil. The stock's GF Value™ is zł938.86, compared to a current price of zł760.00 — trading 19.1% below its estimated fair value. The current EBIT is zł282 Mil. Neuca's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current EBIT is zł282 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (LTS:0MJR) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł760.00 is trading 19.1% below its estimated GF Value™ of zł938.86.

Key valuation signals for LTS:0MJR:

EBIT: zł282 Mil
GF Value™: zł938.86 vs. price of zł760.00 (19.1% below fair value)
GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuca Business Description

Industry Healthcare Medical Distribution

Comparable Companies MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 TSE:2784 SHSE:600739 NZSE:EBO TSE:9987 SHSE:600056 SZSE:000028

Other Exchanges NEU:Poland

Address ul. Forteczna 35‑37, Torun, POL, 87-100

Website https://www.neuca.pl

Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.

98GF Score

Get the complete analysis for LTS:0MJR

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł760.00

Price

zł938.86

GF Value

View LTS:0MJR Analysis

See EBIT data for all stocks →